Latest News

Intravenously administered ketamine shown to reduce symptoms of chronic post-traumatic stress disorder

For the first time, evidence that a single dose of IV-administered ketamine was associated with the rapid reduction of symptoms of post-traumatic stress disorder in patients with chronic PTSD was demonstrated in a proof-of-concept, randomized, double blind crossover study. These findings could be the first step toward developing new interventions for PTSD.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Persistent pain estimated in 19 percent of U.S. Adults

  • Largest study of Hispanics/Latinos finds depression, anxiety rates vary widely among groups

  • Stress-related inflammation may increase risk for depression

  • Animal therapy reduces anxiety, loneliness symptoms in college students

  • Why depression and aging are linked to increased disease risk

  • Panic attacks associated with fear of bright daylight

  • Fish intake associated with boost to antidepressant response

  • I have anxiety, why is my doctor prescribing an antipsychotic? New drug naming system unveiled

  • Women more likely to develop anxiety and depression after heart attack

  • Why me? Many women living in poverty blame children, love life

  •